Article
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2
16 Jul 2021
Abstract excerpt
Abstract Effective and affordable treatments for patients suffering from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are needed. We report in vitro efficacy of Artemisia annua extracts as well as artemisinin, artesunate, and artemether against SARS-CoV-2. The latter two are approved active pharmaceutical ingredients of anti-malarial drugs....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
